A Fresh Approach to Treating Cancer: Targeting Proteins

(DGIwire) – Many headlines from the world of cancer research are focusing on the potential of checkpoint inhibitors—a way of releasing the brakes on immune cells so they can attack cancer cells. But as recently noted on LifeScienceLeader.com, some companies are exploring drugs that could work in combination with checkpoint inhibitors in the hopes of […]

Taking Better Aim at Tumors

(DGIwire) – When it comes to treating cancer, chemotherapy and immunotherapy have proven to be powerful within certain limits. Take immunotherapy: Despite its great promise, it doesn’t help every patient to which it is given—and its track record of success is uneven among different cancers. So notes Douglas J. Swirsky, President and CEO of Rexahn […]

What’s Next in the Fight Against Pancreatic Cancer?

(DGIwire) – Sobering news from the world of medicine: More than 56,000 Americans will be diagnosed with pancreatic cancer in 2019, according to a recent estimate by the American Cancer Society. This represents a two percent increase over the previous year’s diagnoses. While the ACS also states that the disease’s five-year survival rate continues to […]

For Cancer Immunotherapy Patients, a ‘One-Two Punch’ Could Hold Promise

(DGIwire) – Immunotherapy, in which the human immune system is harnessed to treat cancer, has shown great promise but relatively few patients have responded significantly. Among strategies to enhance its power, one of the most intriguing involves so-called “combination” therapies—a “one-two punch” in which immunotherapy is administered along with another type of therapeutic. In recent […]

Why the Future of Cancer Immunotherapy Looks Bright

(DGIwire) – Cancer immunotherapy is a field of medicine that aims to identify treatments for cancer by enhancing the human body’s immune response. According to a recent review article in Frontiers of Immunology, this form of treatment has witnessed a surge in interest in recent years and is likely to transform the treatment of many […]

Giving Immunotherapy and Chemotherapy a Molecular Boost

(DGIwire) – Immunotherapy has shown great promise in cancer care. However, not all patients respond to it—spurring a search for ways to make it more effective. One of the most intriguing strategies involves so-called “combination treatments” in which immunotherapy and chemotherapy are given in tandem with additional agents. In recent years, researchers have identified several […]

Bladder Cancer: 3 Things to Know

(DGIwire) – More than 81,000 U.S. adults were diagnosed with bladder cancer in 2017, according to the American Society for Clinical Oncology (ASCO). For those who have been diagnosed with this disease—or are curious to learn more about it—the first step is getting up to speed on the basics. While there is no substitute for […]

What’s Best for Breast Cancer: The Possibilities of Enhancing Immunotherapy

(DGIwire) – Could the advent of immunotherapy mean a brighter future for breast cancer treatment? As recently noted in an article in TIME magazine, many researchers think it might. They have set their sights on finding ways to retrain the body to recognize and destroy tumor cancer cells—a strategy that is making immune-based treatments the […]

A Nobel-Worthy Advance: Battling Cancer by Retooling the Body’s Immune Response

(DGIwire) – Immunotherapy—the method of harnessing the body’s own immune system to attack and kill cancer cells—is not just one of the most exciting frontiers in medicine today; it is now officially Nobel Prize-winning work. As recently reported by the Pancreatic Cancer Action Network and many other media outlets, two pioneers in the field—Drs. James […]

close